miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity.

导出 LinkOut

翻译打印收藏纠错

第一作者： Long,Jia

第一单位： Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China.

作者： Long,Jia ^[1] ; Qing,Xi ^[1] ; Huafeng,Wang ^[2] ; Zimu,Zhang ^[1] ; Hongkun,Liu ^[1] ; Yingnan,Cheng ^[1] ; Xiangdong,Guo ^[1] ; Jieyou,Zhang ^[1] ; Qi,Zhang ^[1] ; Lijuan,Zhang ^[1] ; Zhenyi,Xue ^[1] ; Yan,Li ^[1] ; Yurong,Da ^[1] ; Peng,Zhao ^[3] ; Rongxin,Zhang ^[4]

作者单位： Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China. ^[1] School of Life Science, Shanxi Normal University, Linfen, China. ^[2] Department of Colorectal Cancer, Tianjin Medical University, Cancer Institute and Hospital, Tianjin, China. ^[3] Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, China; Laboratory of Immunology and Inflammation, Guangdong Pharmaceutical University, Guangzhou, China. Electronic address: rongxinz@yahoo.com. ^[4]

关键词 Pancreatic cancer Programmed cell death 1(PD-1)Programmed death-ligand 1 (PD-L1)T lymphocytes Tumor immunity miR-142-5p